CP
LMAT icon

Castleview Partners’s LeMaitre Vascular LMAT Stock Holding History

Castleview Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,066
Closed -$270K – 972
2024
Q1 		$270K Buy
+4,066
New +$251K 0.15% 148
2022
Q1 		– Sell
-10,899
Closed -$217 – 880
2021
Q4 		$217 Buy
+10,899
New +$563K ﹤0.01% 659

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Castleview Partners's LMAT Position: Q2 2024 in Review

Castleview Partners sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 4,066 shares — an estimated $270K sold.

Castleview Partners first reported a position in LMAT in Q4 2021 and held it in 2 quarters. The position peaked at $270K in Q1 2024. 261 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • Castleview Partners reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • Castleview Partners sold 4,066 LeMaitre Vascular shares in Q2 2024, an estimated $270K.
  • Castleview Partners first reported a position in LeMaitre Vascular in Q4 2021 and held it in 2 quarters.
  • Castleview Partners's LeMaitre Vascular position peaked at $270K in Q1 2024.
  • 261 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on Castleview Partners's 13F filing for Q2 2024, filed 31 Jul 2024.